Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 11 hours agoA potential approval will also show that Moderna isn't just a one-product company and instead can build a billion-dollar respiratory vaccine portfolio,...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 5 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 1 day agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 4 days agoThe FDA has informed Moderna that it is working to conclude...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 6 days agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the ...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 4 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...